Aspire Biopharma Holdings, Inc. Warrant (ASBPW)

EARNINGS ANALYTICS

Earnings reactions

How ASBPW moved on each past earnings report.

Up Down

Earnings Impact

Aspire Biopharma Holdings, Inc. Warrant (ASBPW) is a warrant and does not report quarterly earnings, so there is no earnings-reaction history to display.

Historical Earnings Statistics

Aspire Biopharma Holdings, Inc. Warrant (ASBPW) is a warrant and does not report quarterly earnings, so there is no earnings-reaction history to display.

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±0.00%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 4 →

Funds holding

$88572

Total value held

Buying

4 added · 0 reduced

Morgan Stanley

$79264 NEW BUY

Toronto Dominion Bank

$5150 NEW BUY

Jpmorgan Chase & Co

$4013 +173.00%

Barclays Plc

$145 NEW BUY

SEC Filing Types

description SCHEDULE 13G

2 chevron_right

description 10-Q

1 chevron_right

description SCHEDULE 13G/A

1 chevron_right

description UPLOAD

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260720	open_in_new SEC.gov
SCHEDULE 13G	20260702	open_in_new SEC.gov
8-K	20260622	open_in_new SEC.gov
8-K	20260612	open_in_new SEC.gov
8-K	20260612	open_in_new SEC.gov
10-Q	20260515	open_in_new SEC.gov
SCHEDULE 13G	20260515	open_in_new SEC.gov
8-K	20260514	open_in_new SEC.gov
SCHEDULE 13G/A	20260513	open_in_new SEC.gov
CORRESP	20260413	open_in_new SEC.gov